Your session is about to expire
← Back to Search
High vs Low Dose Rate Brachytherapy for Prostate Cancer
Study Summary
This trial is testing two different types of radiation therapy to see which is better at treating prostate cancer.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have not taken alpha-reductase inhibitors in the last 90 days.I do not have any serious health issues that would stop me from following the study's requirements.I am being actively monitored for my condition, it's getting worse, and I had a prostate biopsy in the last 9 months.I have a history of unusual bleeding or clotting.I have undergone hormone therapy for cancer.I have had major surgery, radiation, chemotherapy, TURP, or cryosurgery for prostate cancer.My cancer has spread to other parts of my body.My prostate cancer was confirmed by a biopsy within the last 9 months.
- Group 1: Arm 3 HDR
- Group 2: Arm 1 LDR
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
In how many venues is this research project being conducted?
"Presently, the study is enrolling participants from 6 locations: Ottawa, Toronto and Montreal among them. To reduce travel costs for those who choose to participate, it is advisable to select a research centre nearby."
Are there any openings for enrollment in this clinical experiment right now?
"Affirmative. According to the information available on clinicaltrials.gov, this scientific research is actively recruiting participants. Initially posted on November 4th 2016 and last updated September 12th 2022, it seeks 232 individuals from 6 sites for participation."
What is the cap on enrolment for this clinical research?
"Indeed, the information hosted on clinicaltrials.gov attests to this trial's recruitment status; it was initially submitted on November 4th 2016 and then updated September 12th 2022. 232 participants need to be recruited from 6 different healthcare facilities."
Share this study with friends
Copy Link
Messenger